Defining Heart Failure Based on Imaging the Heart and Beyond
- PMID: 37427007
- PMCID: PMC10326661
- DOI: 10.15420/cfr.2022.29
Defining Heart Failure Based on Imaging the Heart and Beyond
Abstract
Water and salt retention, in other words congestion, are fundamental to the pathophysiology of heart failure and are important therapeutic targets. Echocardiography is the key tool with which to assess cardiac structure and function in the initial diagnostic workup of patients with suspected heart failure and is essential for guiding treatment and stratifying risk. Ultrasound can also be used to identify and quantify congestion in the great veins, kidneys and lungs. More advanced imaging methods might further clarify the aetiology of heart failure and its consequences for the heart and periphery, thereby improving the efficiency and quality of care tailored with greater precision to individual patient need.
Keywords: Congestion; heart failure; inferior vena cava; jugular vein; ultrasound.
Copyright © 2023, Radcliffe Cardiology.
Conflict of interest statement
Disclosure: FJG has received financial support from Pharmacosmos for travel to international meetings. RTC has received grants and honoraria from AstraZeneca and has participated in an advisory board for Bayer HealthCare Pharmaceuticals LLC. JGFC has received funding from British Heart Foundation; personal fees from Abbott, Amgen, Novartis, Medtronic, Idorsia, Servier, AstraZeneca, Innolife, Torrent and Respicardia; grants and personal fees from Bayer, Bristol Myers Squibb, Vifor, Johnson & Johnson, Myokardia and Viscardia; personal fees and non-financial support from Boehringer Ingelheim and NI Medical; and grants from Pharma Nord and Pharmacosmos. PP has received consultancy honoraria and/or sponsorship support from Boehringer Ingelheim, Pharmacosmos, Novartis, Vifor, AstraZeneca and Caption Health; and research support from Bristol Myers Squibb. All other authors have no conflicts of interest to declare.
Figures
References
-
- Bozkurt B, Coats AJ, Tsutsui H et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021;27:387–413. doi: 10.1016/j.cardfail.2021.01.022. - DOI - PubMed
-
- Cleland JGF, Ferreira JP, Mariottoni B et al. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the Heart “OMics” in AGEing (HOMAGE) randomized clinical trial. Eur Heart J. 2021;42:684–96. doi: 10.1093/eurheartj/ehaa758. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
